ARCHIVES

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

This article is from The Cancer Letter archive.

Vol. 38 No. 08 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials

December 2, 1977

New Government-Wide Regulatory Policy Set For Carcinogens; Industry Group Says They are Not Scientific

October 5, 1979

Study: Keytruda Improves PFS In Ipilimumab-Refactory Disease

November 28, 2014

Denman Hammond, NCCF Founder, Receives Award.

November 17, 2000

US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.

March 30, 2001

In Brief: Ronald Levy, George Stevenson To Share First Hammer Prize; President Reappoints Hammer

December 3, 1982